Skip to main content

Affinity Asset Advisors, LLC

Position in TVTX — Travere Therapeutics, Inc.

CIK 1773195 NEW YORK, NY

Position in TVTX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$17,043,000
+$8,130,000 QoQ
Shares Held
300,000
0.0% QoQ
Ownership
0.318%
of shares outstanding
% of Portfolio
0.86%
of 13F equity value
Holder Rank
#55
of 317 holders
Holding Since
Mar 2021
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TVTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Affinity Asset Advisors, LLC holds $1,842,784,374 across 87 Biotechnology names. TVTX ranks #33 (0.9% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TVTX

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $17,043,000 300,000
2026-03-31 $8,913,000 300,000
2025-12-31 $11,463,000 300,000
2025-09-30 $11,950,000 500,000
2025-06-30 $14,356,000 970,000
2025-03-31 $19,174,400 1,070,000
2024-12-31 $3,484,000 200,000
2024-03-31 $963,750 125,000
2023-09-30 $894,000 100,000
2022-03-31 $2,577,000 100,000
2021-12-31 $1,552,000 50,000
2021-09-30 $4,850,000 200,000
2021-03-31 $5,493,400 220,000